Results 191 to 200 of about 65,278 (248)

Working Group on drug-related deaths:Report and recommendations [PDF]

, 2005
, Busuttil, Anthony, Jackson, Graham, Jay, Jane, Kidd, Brian, Marsden, Andrew, McCarron, Mike, Norrie, Karen, Perry, Samantha, Reith, Bill, Roberts, Kay, Simpson, Richard, Spiers, David, Wood, Gillian, Wood, Tom, Zador, Deborah   +15 more
core   +1 more source

Barriers and facilitators to initiating and adhering to harm reduction services among people who inject drugs in the United States: a systematic review. [PDF]

Harm Reduct J
Nacht CL, Skaathun B, Ogarrio K, Durbin-Matrone R, Wright L, Reich R, Reich K, Stojanovski K.   +7 more
europepmc   +1 more source

Propranolol Administration During Morphine Addiction Attenuates Reinstatement of Drug-Aversive Memories Caused by Exposure to Stressful Stimuli. [PDF]

Pharmaceuticals (Basel)
Cánovas-Cabanes A, Teruel-Fernández FJ, Fernández-López L, Martínez-Laorden E, Navarro-Zaragoza J, Almela P.   +5 more
europepmc   +1 more source

Examining rural community pharmacists' knowledge and practices in opioid overdose prevention and treatment services in the Southeastern United States. [PDF]

Harm Reduct J
Ferreri SP, Ngo PQ, Yen KD, Wang K, Hughes TD.   +4 more
europepmc   +1 more source

Thyroid dysfunction in African trypanosomiasis [PDF]

, 1993
Allolio, B., Arlt, W., Chrousos, G. P., Heppner, C., Mbulamberi, D., Petzke, F., Reincke, Martin, Siekmann, L., Vollmer, D., Winkelmann, W.   +9 more
core  

Opioids regulate the functional state of immune cells and reduce inflammatory cardiac injury: Role of opioid receptors, MRGPRX2, and TLR4. [PDF]

J Biomed Res
Gusakova SV, Sirotina M, Maslov LN, Slidnevskaya AS, Kilin M, Kurbatov BK, Kan A, Derkachev IA, Fu F.   +8 more
europepmc   +1 more source

Naloxone Availability, Testing Drugs for Potency, and Solitary Use: Unpacking the Determinants of Overdose Prevention Behaviors. [PDF]

Subst Use Misuse
Latkin CA, Dayton L, Bonneau H, Davey-Rothwell MA, Santos-Silva L, Yi G, Falade-Nwulia O.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Naloxone

Annals of Emergency Medicine, 1983
Naloxone hydrochloride, a synthetic N-allyl derivative of oxymorphone, is an effective agent for the reversal of the cardiovascular and respiratory depression associated with narcotic and possibly some non-narcotic overdoses. It is essentially a pure narcotic antagonist, is relatively safe, and is a useful diagnostic and therapeutic agent.
K A, Handal, J L, Schauben, F R, Salamone   +2 more
openaire   +3 more sources

Perinatal naloxone: When does naloxone affect hyperalgesia?

Pharmacology Biochemistry and Behavior, 1979
Pregnant mice were treated with naloxone via subcutaneous implants, from about 5 days prior to parturition. At birth entire litters were cross-fostered so that groups of offspring were exposed to naloxone treated mothers; before birth, after birth to weaning, from about 5 days prior to birth to weaning, or not exposed to naloxone.
H, Monder, N, Yasukawa, J J, Christian
openaire   +2 more sources

Naloxone

Reactions Weekly, 2020
Louis A. Pagliaro, Ann Marie Pagliaro
  +7 more sources